Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
1.070
-0.070 (-6.14%)
At close: Mar 12, 2026, 4:00 PM EDT
1.080
+0.010 (0.93%)
After-hours: Mar 12, 2026, 7:10 PM EDT
Hoth Therapeutics Market Cap
Hoth Therapeutics has a market cap or net worth of $16.6 million as of March 12, 2026. Its market cap has increased by 128.28% in one year.
Market Cap
16.60M
Enterprise Value
8.77M
1-Year Change
128.28%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since February 15, 2019, Hoth Therapeutics's market cap has decreased from $80.39M to $16.60M, a decrease of -79.35%. That is a compound annual growth rate of -19.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 16.60M | 8.08% |
| Dec 31, 2025 | 15.36M | 166.64% |
| Dec 31, 2024 | 5.76M | -7.96% |
| Dec 29, 2023 | 6.26M | -38.29% |
| Dec 30, 2022 | 10.14M | -35.89% |
| Dec 31, 2021 | 15.82M | -50.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 19.10M |
| Intensity Therapeutics | 18.80M |
| IN8bio | 18.65M |
| Longeveron | 17.26M |
| Lexaria Bioscience | 16.89M |
| Serina Therapeutics | 16.83M |
| Cadrenal Therapeutics | 16.79M |
| Traws Pharma | 16.14M |